Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overall Survival”

367 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 367 results

Not applicableStudy completedNCT02603315
What this trial is testing

Vascularity Impact on the Treatment Outcome in Malignant Pleural Mesothelioma(VITMPM)

Who this might be right for
Malignant Pleural Mesotheliomas
Ain Shams University 50
Not applicableLooking for participantsNCT07120529
What this trial is testing

Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.

Who this might be right for
Cervical CancerHysterectomy
Medical University of Silesia 300
Testing effectiveness (Phase 2)Study completedNCT00767377
What this trial is testing

Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC

Who this might be right for
Gastric Cancer
Fudan University 163
Not applicableUnknownNCT03967457
What this trial is testing

Comprehensive Study on the Quality of Life in Cervical Cancer Patients

Who this might be right for
Quality of LifeCervical CancerUrodynamics+7 more
Lei Li 10,000
Not applicableUnknownNCT03701659
What this trial is testing

TUPKRP Combined With MAB Therapy for LUTS/PCa

Who this might be right for
Advanced Prostate CancerLower Urinary Tract SymptomsQuality of Life+2 more
The Third Xiangya Hospital of Central South University 100
Testing effectiveness (Phase 2)Ended earlyNCT03729297
What this trial is testing

Cabozantinib in Advanced Salivary Gland Cancer Patients

Who this might be right for
Salivary Gland Cancer
Radboud University Medical Center 25
Not applicableUnknownNCT03631459
What this trial is testing

Real World Study of Kanglaite for Cancer Cachexia

Who this might be right for
Cancer Cachexia
Zhejiang Kanglaite Pharmaceutical Co.Ltd 100,000
Not applicableStudy completedNCT06525675
What this trial is testing

Study to Evaluate the Extended Overall Survival (OS) Data From PARSIFAL Study (The PARSIFAL-LONG Study)

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerLuminal Breast Cancer+2 more
MedSIR 419
Testing effectiveness (Phase 2)UnknownNCT03799094
What this trial is testing

Vitamin C and Tyrosine Kinase Inhibitor in Lung Cancer Patients With Epidermal Growth Factor Receptor Mutations

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Clifford Hospital, Guangzhou, China 150
Large-scale testing (Phase 3)Ended earlyNCT01200212
What this trial is testing

Study to Determine the Efficacy of a Taxane and Bevacizumab With or Without Capecitabine as First Line Chemotherapy in Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 432
Testing effectiveness (Phase 2)Temporarily pausedNCT02008019
What this trial is testing

A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas

Who this might be right for
Chondrosarcoma
Centre Leon Berard 57
Not applicableLooking for participantsNCT06215495
What this trial is testing

A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial

Who this might be right for
Radiation ToxicityMRI Simulated PositioningHigh Grade Glioma+2 more
Zhujiang Hospital 88
Not applicableStudy completedNCT04161911
What this trial is testing

Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy

Who this might be right for
Hepatocellular Carcinoma
Bristol-Myers Squibb 1,426
Testing effectiveness (Phase 2)Ended earlyNCT00613730
What this trial is testing

Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint

Who this might be right for
Cancer of PancreasCancer of the PancreasPancreas Cancer+1 more
Amgen 3
Post-approval studies (Phase 4)Ended earlyNCT00642733
What this trial is testing

First Line Treatment With Tarceva (Erlotinib) in Combination With Gemcitabine in Patients With Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Hoffmann-La Roche 6
Testing effectiveness (Phase 2)UnknownNCT04699214
What this trial is testing

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Who this might be right for
Other Disorders of Soft Tissues
Yong Chen 210
Large-scale testing (Phase 3)Looking for participantsNCT04876651
What this trial is testing

The Present Study Aims to Compare Patients Who Receive the Investigational Product (177Lu-DOTA-rosopatamab) Plus Standard of Care, in Comparison to Standard of Care Only

Who this might be right for
Metastatic Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Ltd 392
Post-approval studies (Phase 4)WithdrawnNCT00510627
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Who this might be right for
Metastatic Liver CancerSecondary Liver CancerLiver Neoplasm
Boston Scientific Corporation
Not applicableActive Not RecruitingNCT07075939
What this trial is testing

Centralization and Oncologic Outcomes in Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerOvarian NeoplasmsAdvanced Ovarian Cancer
Azienda USL Reggio Emilia - IRCCS 200
Large-scale testing (Phase 3)Study completedNCT00556712
What this trial is testing

Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 889
Load More Results